How does pioglitazone prevent progression of impaired glucose tolerance to diabetes?
- PMID: 24158994
- PMCID: PMC3806606
- DOI: 10.2337/db13-1175
How does pioglitazone prevent progression of impaired glucose tolerance to diabetes?
Figures
Comment on
-
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates.Diabetes. 2013 Nov;62(11):3920-6. doi: 10.2337/db13-0265. Epub 2013 Jul 17. Diabetes. 2013. PMID: 23863810 Free PMC article. Clinical Trial.
References
-
- Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999;48:937–942 - PubMed
-
- Wilson PW. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am 2001;30:857–881 - PubMed
-
- Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–444 - PubMed
-
- Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413–420 - PubMed
-
- Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010;55:1310–1317 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
